SNYNF

Sanofi OTC

Healthcare ·Drug Manufacturers - General ·FR · sanofi.com

$89.45

Mkt Cap $107.4B

52w Low $85.74 16.4% of range 52w High $108.40

50d MA $92.55 200d MA $95.75

P/E (TTM) 14.3x

EV/EBITDA 16.9x

P/B 1.6x

Debt/Equity 0.3x

ROE 17.0%

P/FCF 11.2x

RSI (14) —

ATR (14) —

Beta 0.32

50d MA $92.55

200d MA $95.75

Avg Volume 26.4K

About

Sanofi, together with its subsidiaries, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through three segments: Pharmaceuticals, Vaccines, and Consumer Healthcare. The company provides specialty care products, including human monoclonal antibodies; products for multiple sclerosis, neurology, ot…

Recent Earnings

Date	Time	Est	Rptd	Surp	Base	Gap%	D1%	D2%	D3%	D4%	D5%	Guide ▲★
Apr 23, 2026	AMC	—	1.54	—	92.44	+0.0%	+0.0%	+2.8%	+2.8%	+0.9%	-0.7%	—
Jan 29, 2026	AMC	1.65	1.95	+18.2%	91.11	+0.0%	+0.0%	+4.2%	+4.2%	+4.2%	+3.3%	—
Jul 31, 2025	AMC	—	3.76	—	92.60	-0.0%	-0.0%	+0.2%	+0.2%	+0.2%	+2.0%	—
Apr 24, 2025	AMC	1.69	1.79	+5.9%	106.45	-1.4%	-3.4%	-3.4%	+4.3%	+6.8%	+4.8%	—
Jan 30, 2025	AMC	1.69	1.31	-22.5%	108.00	-0.5%	+0.3%	-3.7%	-3.7%	-2.0%	-2.0%	—
Oct 25, 2024	AMC	2.48	2.86	+15.3%	102.35	+3.6%	+9.3%	+2.4%	+2.4%	+2.6%	+6.2%	—
Jul 25, 2024	AMC	1.67	1.73	+3.6%	105.61	+0.0%	+0.0%	+0.0%	-5.1%	-5.1%	-5.1%	—
Apr 25, 2024	AMC	1.73	1.78	+2.9%	95.54	+0.0%	+0.0%	+0.0%	+0.0%	+4.7%	+4.7%	—
Feb 1, 2024	AMC	1.68	1.66	-1.2%	96.59	+0.0%	+0.0%	+0.0%	+0.0%	-3.0%	-4.6%	—
Oct 27, 2023	AMC	2.61	2.55	-2.3%	86.12	+2.8%	+2.8%	+3.8%	+7.4%	+7.4%	+5.5%	—
Jul 28, 2023	AMC	1.63	1.74	+6.7%	105.20	+0.1%	+0.1%	+0.8%	-2.0%	-3.5%	-3.5%	—
Apr 27, 2023	AMC	2.01	2.16	+7.5%	111.35	-1.2%	-3.9%	-0.0%	-3.5%	-3.5%	-3.5%	—

Recent Analyst Ratings

Date	Firm	Action	Grade	Target	Base	Open	Gap%	D1%	D2%	D3%	D4%	D5%
Mar 26	Argus	Maintains	Buy → Buy	—	—	—	—	—	—	—	—	—
Aug 11	Deutsche Bank	Upgrade	Sell → Hold	—	$87.40	$87.79	+0.4%	-1.0%	-2.0%	-3.4%	+2.4%	-3.6%
Sep 26	SVB Leerink	Upgrade	Market Perform → Outperform	—	—	—	—	—	—	—	—	—
Mar 10	Goldman Sachs	Upgrade	Neutral → Buy	—	$94.18	$91.45	-2.9%	-5.5%	-6.0%	-15.3%	-10.8%	-15.2%
Feb 18	Argus	Maintains	Buy → Buy	—	$100.25	$100.25	+0.0%	+0.0%	-0.0%	-0.5%	-0.5%	-0.5%
Jan 5	JP Morgan	Upgrade	Neutral → Overweight	—	—	—	—	—	—	—	—	—
Dec 5	Barclays	Downgrade	Equal Weight → Underweight	—	$93.58	$94.05	+0.5%	+0.5%	+0.0%	-1.8%	-1.8%	-2.3%
Sep 22	Guggenheim	Upgrade	Neutral → Buy	—	—	—	—	—	—	—	—	—
Nov 7	Argus	Maintains	Buy → Buy	—	$88.56	$88.56	+0.0%	+0.0%	+0.0%	+3.3%	-0.7%	-1.2%
Oct 31	Barclays	Upgrade	Underweight → Equal Weight	—	$84.63	$89.60	+5.9%	+5.9%	+5.3%	+5.3%	+5.2%	+4.6%
Sep 9	BofA Securities	Upgrade	Neutral → Buy	—	—	—	—	—	—	—	—	—
Aug 23	Argus	Maintains	Buy → Buy	—	$80.52	$86.15	+7.0%	+7.2%	+7.8%	+7.3%	+7.9%	+7.4%
Aug 9	Citigroup	Upgrade	Neutral → Buy	—	$87.97	$86.15	-2.1%	-2.1%	-6.1%	-4.7%	-5.9%	-6.4%
Jan 22	Barclays	Downgrade	Equal Weight → Underweight	—	$87.59	$86.48	-1.3%	-0.2%	+0.7%	+1.6%	+1.1%	+1.1%
Nov 14	Barclays	Upgrade	Underweight → Equal Weight	—	$91.16	$89.15	-2.2%	-2.2%	-2.3%	-2.9%	-3.3%	-3.3%
Aug 29	HSBC	Upgrade	Reduce → Hold	—	$96.82	$96.82	+0.0%	+0.0%	+0.0%	+0.4%	-0.1%	-0.1%
May 11	Barclays	Upgrade	Equal Weight → Overweight	—	$79.76	$78.60	-1.5%	-1.5%	-0.8%	-1.5%	-0.8%	-1.0%
May 2	HSBC	Downgrade	Buy → Hold	—	$82.13	$82.76	+0.8%	+0.3%	+1.4%	-1.1%	-2.2%	-2.7%
Dec 9	Exane BNP Paribas	Downgrade	Neutral → Underperform	—	$86.27	$84.80	-1.7%	-1.8%	-3.5%	-3.9%	-3.3%	-0.6%
Nov 30	Morgan Stanley	Downgrade	Overweight → Equal Weight	—	$89.51	$89.06	-0.5%	-0.5%	-0.5%	-2.6%	-3.8%	-3.8%
Nov 8	Bernstein	Downgrade	Outperform → Market Perform	—	—	—	—	—	—	—	—	—
Nov 8	Bryan Garnier	Downgrade	Buy → Neutral	—	—	—	—	—	—	—	—	—
Mar 16	Leerink Swann	Upgrade	Market Perform → Outperform	—	$93.73	$97.60	+4.1%	+4.0%	+3.5%	+6.5%	+5.5%	+7.8%
Oct 28	Jefferies	Downgrade	Buy → Hold	—	$105.50	$95.00	-10.0%	-9.9%	-14.7%	-14.2%	-13.0%	-14.0%
Oct 28	BofA Securities	Downgrade	Buy → Neutral	—	$105.50	$95.00	-10.0%	-9.9%	-14.7%	-14.2%	-13.0%	-14.0%
Oct 28	Barclays	Downgrade	Overweight → Equal Weight	—	$105.50	$95.00	-10.0%	-9.9%	-14.7%	-14.2%	-13.0%	-14.0%
Oct 28	Deutsche Bank	Downgrade	Buy → Hold	—	$105.50	$95.00	-10.0%	-9.9%	-14.7%	-14.2%	-13.0%	-14.0%
Oct 27	Deutsche Bank	Downgrade	Buy → Hold	—	$107.59	$105.50	-1.9%	-1.9%	-11.6%	-16.3%	-15.9%	-14.7%
Jan 22	Citigroup	Downgrade	Buy → Neutral	—	$103.15	$102.70	-0.4%	-0.3%	-1.5%	-4.8%	-4.1%	-4.5%
Jan 8	S&P Capital IQ	Downgrade	Buy → Hold	—	$103.72	$102.58	-1.1%	-1.1%	-1.9%	-2.4%	-2.4%	-2.4%
Jan 5	JP Morgan	Downgrade	Overweight → Neutral	—	—	—	—	—	—	—	—	—
Nov 17	Kepler Cheuvreux	Upgrade	Hold → Buy	—	—	—	—	—	—	—	—	—
Nov 14	Mirabaud Securities	Upgrade	Neutral → Buy	—	$104.05	$106.59	+2.4%	+2.4%	+3.8%	+5.0%	+4.5%	+3.7%
Oct 30	Natixis	Upgrade	Neutral → Buy	—	$104.75	$104.23	-0.5%	-0.5%	+3.3%	+2.8%	+1.4%	+0.9%
Oct 17	Leerink Swann	Downgrade	Outperform → Market Perform	—	$98.50	$98.01	-0.5%	-0.5%	+2.4%	+1.9%	+3.8%	+4.7%
Sep 15	Barclays	Upgrade	Equal Weight → Overweight	—	—	—	—	—	—	—	—	—
Aug 20	Cowen & Co.	Downgrade	Outperform → Market Perform	—	$102.49	$103.20	+0.7%	+0.7%	+0.7%	-2.1%	-2.6%	-2.6%
May 2	Banco Sabadell	Downgrade	Buy → Sell	—	$107.31	$109.35	+1.9%	+1.9%	+3.1%	+2.6%	+2.6%	+6.1%
Feb 7	Kepler Cheuvreux	Downgrade	Buy → Hold	—	$94.89	$89.85	-5.3%	-5.6%	-1.4%	+0.1%	+1.0%	+0.5%
Jan 28	Barclays	Downgrade	Overweight → Equal Weight	—	$98.80	$98.20	-0.6%	-1.0%	-0.7%	-0.3%	-0.8%	-0.6%
Jan 27	Goldman Sachs	Upgrade	Sell → Neutral	—	—	—	—	—	—	—	—	—
Aug 2	Standpoint Research	Downgrade	Buy → Hold	—	$79.30	$79.30	+0.0%	+0.0%	+0.0%	+4.9%	+4.4%	+4.3%

Data updated apr 28, 2026 9:28pm · Source: massive.com